<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Fri, 15 Aug 2025 11:04:06 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Dow Surges Over 200 Points; Flowers Foods Shares Fall After Q2 Results</title><link>https://www.benzinga.com/markets/market-summary/25/08/47155334/dow-surges-over-200-points-flowers-foods-shares-fall-after-q2-results</link><image_url>https://cdn.benzinga.com/files/images/story/2025/08/15/Portland--Or--Usa---Mar-12--2020-Dow-Jon.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>read more</description><pubDate>Fri, 15 Aug 2025 14:58:20 GMT</pubDate></item><item><title>Tiger Global Boosts Big Tech Bets, Ramps Up Portfolio Value By 28% In Q2</title><link>https://www.benzinga.com/markets/hedge-funds/25/08/47155182/tiger-global-boosts-big-tech-bets-ramps-up-portfolio-value-by-28-in-q2</link><image_url>https://cdn.benzinga.com/files/images/story/2025/08/15/Binary-Options-Chart.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Chase Coleman's Tiger Global boosted its portfolio value and reshuffled key holdings in Q2 2025. The firm is known for its aggressive, research-driven...</description><pubDate>Fri, 15 Aug 2025 14:53:27 GMT</pubDate></item><item><title>Why Is Precigen Stock Surging On Friday?</title><link>https://www.benzinga.com/news/fda/25/08/47154782/why-is-precigen-stock-surging-on-friday</link><image_url>https://cdn.benzinga.com/files/images/story/2025/08/15/Medical-research.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Precigen's Papzimeos wins FDA approval as the first therapy for adult recurrent respiratory papillomatosis, showing durable results in clinical trials...</description><pubDate>Fri, 15 Aug 2025 14:48:12 GMT</pubDate></item><item><title>Intel Jumps As Trump Explores Investment In Bid To Revive US Chip Ambitions</title><link>https://www.benzinga.com/trading-ideas/movers/25/08/47154632/intel-jumps-as-trump-explores-investment-in-bid-to-revive-us-chip-ambitions</link><image_url>https://cdn.benzinga.com/files/images/story/2025/08/15/Santa-Clara--Ca--Usa---Nov-22--2023-Inte.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Intel stock gains after report of potential government stake, amid weak balance sheet and delays. Trump's softened stance and CEO meeting. read more</description><pubDate>Fri, 15 Aug 2025 14:45:19 GMT</pubDate></item><item><title>XRP Down 6% In 1 Week As ETH Keeps Pumping: What Is Going On?</title><link>https://www.benzinga.com/crypto/cryptocurrency/25/08/47154180/xrp-down-6-in-1-week-as-eth-keeps-pumping-what-is-going-on</link><image_url>https://cdn.benzinga.com/files/images/story/2025/08/15/XRP-Ripple.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>XRP (CRYPTO: XRP ) is down 6% over the past week, but traders remain upbeat about the tokenâ€™s near-term prospects . read more</description><pubDate>Fri, 15 Aug 2025 14:38:03 GMT</pubDate></item></channel></rss>